稳定型心绞痛和非ST段抬高心肌梗死治疗分析

邱军杰，王西辉

（西安医学院第二附属医院，陕西 西安，710038）

浏览次数：107次 下载次数：398次

摘要：

目的 对稳定性心绞痛和非ST段抬高心肌梗死治疗情况进行分析及判定。方法 选取本院2015年2月至2016年1月收治的稳定性心绞痛患者作为A 组，非ST段抬高心肌梗死患者作为B组，两组患者各100例，选取A组和B组各50例， 对其予以曲美他嗪治疗，分别将其作为对照组A、对照组B，剩余100例患者于对照组A、B治疗的基础上予以葛根素治疗， 分别将其作为观察组A、观察组B，四组患者各50例。观察四组患者治疗后的心绞痛分级情况、硝酸甘油用量情况及活动平板运动试验持续时间。结果 治疗后12周，观察组A、B 的心绞痛Ⅱ、Ⅲ级、硝酸甘油用量情况及活动平板运动试验持续时间均优于治疗前与治疗后对照组A、B（P<0.05）。结论 曲美他嗪联合葛根素在稳定型心绞痛和非ST 段抬高心肌梗死的治疗效果显著，可显著缓解患者的心绞痛症状，降低硝酸甘油使用量，提高心肌功能，值得在临床中推广实施。

关键词：稳定性心绞痛；非ST 段抬高心肌梗死；曲美他嗪；葛根素

中图分类号：R541.4文献标志码：A文章编号：2096-1413(2017)32-0020-02

Treatment analysis of stable angina pectoris and non-ST-elevation myocardial infarction
QIU Jun-jie, WANG Xi-hui
(the Second Affiliated Hospital of Xi``an Medical University, Xi``an 710038, China)

ABSTRACT: Objective To analyze and judge the treatment of stable angina pectoris and non -ST -segment elevation myocardial infarction. Methods Patients with stable angina pectoris treated in our hospital from February 2015 to January 2016 were selected as the group A and the patients with non-ST-segment elevation myocardial infarction were seleced as the group B, with 100 cases in each group. Fifty patients were selected respectively from group A and B, and treated with trimetazidine, and grouped as the control group A and control group B respectively. The other 100 patients in the group A and B received puerarin on the basis of treatment of the control group A, B, were grouped as the observation group A, and B, with 50 cases in each group. The levels of angina pectoris, the dosage of nitroglycerin and the duration of treadmill exercise test were observed in the four groups. Results After treatment for 12 weeks, the grade Ⅱ, Ⅲ of angina pectoris, the dosage of nitroglycerin and the duration of treadmill exercise test of the observation group A and B were better than those before treatment and those of the control group A and B (P<0.05). Conclusion Trimetazidine combined with puerarin in the treatment of stable angina pectoris and non-ST-elevation myocardial infarction has remarkable effect, which can significantly alleviate the symptoms of angina pectoris, reduce the use of nitroglycerin, improve myocardial function, it is worthy of practicing in clinical practice.
KEYWORDS: stable angina; non-ST-segment elevation myocardial infarction; trimetazidine; puerarin

参考文献：
[1] 陈易.地西泮治疗不稳定性心绞痛/非ST 段抬高性心肌梗死的效果观察[J].吉林医学,2015,36(7):1369-1370.
[2] 严玉兰.不稳定性心绞痛和非ST 段抬高心肌梗死诊断的临床护理研究[J].吉林医学,2015,36(18):4174-4175.
[3] 王静.BNP 及CRP 在急性冠状动脉综合征患者外周血中的表达及其与病变严重程度的相关性[J].实用临床医药杂志,2015,19(9):18-20.
[4] 梁安珊.高敏肌钙蛋白检测在非ST 段抬高急性冠状动脉综合征诊断中的价值[J].中国实验诊断学,2014,18(2):250-251.
[5] LUCIA J,LUCIA M,LUCIA J,et al.Effect of ivabradine on endothelial function in patients with stable angina pectoris: assessment with the endo-pat 2000 device[J].Adv Ther,2015,32(10):962-970.
[6] 胡蓉芳.大剂量阿司匹林联合低分子肝素钙对老年人不稳定型心绞痛的疗效观察[J].中外医学研究,2012,10(18):31-32.